Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in Schizophrenia Research
- Vol. 70 (1) , 91-100
- https://doi.org/10.1016/j.schres.2003.11.001
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical AntipsychoticAmerican Journal of Psychiatry, 2003
- Injections of Depot Antipsychotic Medications in Patients Suffering From SchizophreniaThe Journal of Clinical Psychiatry, 2001
- Choosing Antipsychotic Maintenance Therapy - A Naturalistic StudyPharmacopsychiatry, 2000
- Complications at site of injection of depot neurolepticsBMJ, 1995
- The Bioavailability and Pharmacokinetics of Oral and Depot Intramuscular Haloperidol in Schizophrenic PatientsThe Journal of Clinical Pharmacology, 1987
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987
- LOCAL REACTIONS TO I.V. DIAZEPAM IN THREE DIFFERENT FORMULATIONSBritish Journal of Anaesthesia, 1980